Intrinsiqs

Is Ligand Pharmaceuticals Incorporated overvalued?

Ligand Pharmaceuticals Incorporated (LGND) looks overvalued — trading about 36% above its fair value.

Overvalued
Current price $308.79 Fair value $197.56
Price
$308.79
Fair value
$197.56
Current P/E
37.0
Normal P/E
23.7
Market cap
$6.18B
Dividend yield
0.0%
Return on equity
5.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares LGND's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.